Immediate Impact
57 standout
Citing Papers
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
2021 Standout
Supramolecular cancer nanotheranostics
2021 Standout
Works of Rori Salvaggio being referenced
Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a phase II randomized trial of adjuvant dose-dense chemotherapy for women with node-positive breast carcinoma.
2001
Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer.
1996
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Rori Salvaggio | 286 | 55 | 95 | 73 | 12 | 364 | |
| Lisa M. Moy | 154 | 27 | 53 | 80 | 18 | 310 | |
| William C. Wood | 222 | 20 | 104 | 57 | 9 | 331 | |
| Michael Minton | 114 | 47 | 56 | 90 | 13 | 313 | |
| Rebecca Smittenaar | 223 | 46 | 46 | 74 | 14 | 351 | |
| Nancy Paul | 170 | 66 | 91 | 45 | 9 | 396 | |
| K. J. Pandya | 171 | 107 | 74 | 68 | 26 | 337 | |
| Andrew Robinson | 156 | 32 | 55 | 61 | 15 | 332 | |
| Martin Helsing | 271 | 19 | 87 | 164 | 17 | 388 | |
| Mohammed A. Osman | 161 | 49 | 85 | 65 | 22 | 384 | |
| L Holmberg | 155 | 84 | 71 | 51 | 12 | 376 |
All Works
Login with ORCID to disown or claim papers
Loading papers...